Health World Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.

Press releases published on September 1, 2026

3 hours ago

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

CytomX Therapeutics to Present at Upcoming September Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Nurix Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Dianthus Therapeutics to Participate in Three Investor Conferences During September

Indeterminate GlobeNewswire

3 hours ago

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Voyager to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Eyconis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Recovery Month Shines a Light on Hope, Healing, and the Power of Personalized Care at Futures Recovery Healthcare

Indeterminate GlobeNewswire

3 hours ago

Vor Bio To Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

3 hours ago

Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston

Indeterminate GlobeNewswire

3 hours ago

Elevar Therapeutics to Share Camrelizumab/Rivoceranib Poster at International Liver Cancer Association Conference on Clinical Outcomes in Younger Age Patients with Unresectable Hepatocellular Carcinoma

Indeterminate GlobeNewswire

3 hours ago

Scribe Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President

Indeterminate GlobeNewswire

3 hours ago

ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September

Indeterminate GlobeNewswire

3 hours ago

Belite Bio to Participate in Four Upcoming Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

Indeterminate GlobeNewswire

3 hours ago

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth

Indeterminate GlobeNewswire

3 hours ago

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

Indeterminate GlobeNewswire

3 hours ago

Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial

Indeterminate GlobeNewswire

3 hours ago

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Indeterminate GlobeNewswire